Nightstar Announces Planned Initiation of Phase 2/3 Expansion Study in XIRIUS Trial for NSR-RPGR in XLRP Genetics Investing
Myriad Presents Two New Studies at the Western Section of the American Urological Association Genetics Investing
Spark Therapeutics Presents Three Post-hoc Analyses from Phase 3 Clinical Trial of LUXTURNA Genetics Investing
Precipio Expands ICE COLD-PCR Menu for Breast, Colon and Endometrial Cancers Medical Device Investing
New Studies Highlight Performance of Vectra Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofacitinib and Rituximab Genetics Investing
Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin Test in China Genetics Investing